SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN)

259 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2021.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 222 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 54,148,773 shares of 56,047,431 outstanding shares and own 96.6% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8,872,052 shares), VANGUARD GROUP INC (5,484,424 shares), ARMISTICE CAPITAL, LLC (3,324,000 shares), DIMENSIONAL FUND ADVISORS LP (2,276,185 shares), MACQUARIE GROUP LTD (2,135,923 shares), STATE STREET CORP (1,827,480 shares), LOOMIS SAYLES & CO L P (1,619,065 shares), GW&K Investment Management, LLC (1,616,100 shares), RENAISSANCE TECHNOLOGIES LLC (1,516,222 shares), and Stephens Investment Management Group LLC (1,245,329 shares).
This table shows the top 222 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.